Altoida, Inc.
PrivateLast Round
Series A
Mar 30, 2022
Total Funding Raised
$28.33M
Company Overview
Altoida, Inc. is a healthcare technology company that provides a precision neurology platform using AI and augmented reality to assess cognitive function and aid in the early detection of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altoida, Inc. Comparables
Compare Altoida, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cumulus Neuroscience | 86% | |
| NeuraLight | 85% | |
| Ad Scientiam | 84% | |
Altoida, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 30, 2022 | ||||
| Grant | Sep 9, 2021 | ||||
| Series A | Jul 12, 2021 | ||||
| Series A Extension | May 4, 2020 | ||||
| Series A | May 31, 2019 | ||||
Seed | Dec 30, 2016 |
Altoida, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grey Sky Venture Partners | Series A |
| M Ventures | Series A |
| Eisai Innovation | Series A |
| VI Partners | Series A, Seed |
| Fyrfly Venture Partners | Series A, Seed |
| b2venture | Series A |
| Alpana Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2021
Led by Eisai Innovation
- Dec 30, 2016
$1.2M round led by Fyrfly Venture Partners.
Altoida, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Altoida, Inc.'s valuation, stock price, and market status.